These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3396030)

  • 1. [The effect of dihydroderivatives of ergotoxine on parameters of liver circulation].
    Hrdina R; Grossmann V
    Cas Lek Cesk; 1988 Apr; 127(16):496-8. PubMed ID: 3396030
    [No Abstract]   [Full Text] [Related]  

  • 2. Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus.
    Kosar E; Sumová A; Jakoubek B
    Physiol Bohemoslov; 1986; 35(4):334-9. PubMed ID: 3020603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the hydrogenated ergotoxine-group alkaloids on the intact human uterus.
    GARRETT WJ; EMBREY MP
    J Obstet Gynaecol Br Emp; 1955 Aug; 62(4):523-9. PubMed ID: 13252453
    [No Abstract]   [Full Text] [Related]  

  • 4. [The non-specific pharmacodynamic action of certain alkaloids of Secale cornutum (ergotaminum hydrotartaricum, DH-ergotoxine, ergometriunum maleicum) in chronic treatment on genital tract reactivity].
    Simionescu S; Bordeianu A; Mateescu-Cantuniari A; Militaru M; Boca A
    Physiologie; 1983; 20(1):53-64. PubMed ID: 6405409
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of various hydrogenated derivatives of ergotoxine on experimental hyperthyroidism in guinea pigs. I].
    QUATRINI U; CASCIO G; SOLARO M
    Arch Fisiol; 1955 Dec; 55(4):343-8. PubMed ID: 13314862
    [No Abstract]   [Full Text] [Related]  

  • 6. Ergotoxine inhibition of deciduoma formation and its reversal by progesterone.
    SHELESNYAK MC
    Am J Physiol; 1954 Nov; 179(2):301-4. PubMed ID: 13218163
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure to detect estrogenic or gonadotrophic activity in ergotoxine.
    SHELESNYAK MC
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):457-8. PubMed ID: 13408291
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of adrenalectomy to interfere with ergotoxine-induced interruption of early pregnancy in the rat.
    SHELESNYAK MC
    J Endocrinol; 1956 Aug; 14(1):37-9. PubMed ID: 13357679
    [No Abstract]   [Full Text] [Related]  

  • 9. Gonadotrophin content of pituitary of pregnant and pseudopregnant rats following single injection of ergotoxine.
    SHELESNYAK MC
    Endocrinology; 1957 Jun; 60(6):802-3. PubMed ID: 13427706
    [No Abstract]   [Full Text] [Related]  

  • 10. Disturbance of hormone balance in the female rat by a single injection of ergotoxine ethanesulphonate.
    Shelesnyak MC
    Am J Physiol; 1955 Jan; 180(1):47-9. PubMed ID: 13228644
    [No Abstract]   [Full Text] [Related]  

  • 11. Progesterone reversal of ergotoxine induced suppression of early - pre-implantation - pregnancy.
    SHELESNYAK MC
    Acta Endocrinol (Copenh); 1956 Oct; 23(2):151-7. PubMed ID: 13372157
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance of gestation of ergotoxine-treated pregnant rats by exogenous prolactin.
    SHELESNYAK MC
    Acta Endocrinol (Copenh); 1958 Jan; 27(1):99-109. PubMed ID: 13497524
    [No Abstract]   [Full Text] [Related]  

  • 13. Ergotoxine hyper- and hypothermia in albino rats.
    BUCHANAN AR; ROBERTS JE; ROBINSON BE
    Proc Soc Exp Biol Med; 1948 May; 68(1):143-50. PubMed ID: 18863702
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of ergotoxine inhibition of deciduoma by M.E.D. of progesterone in spayed pseudopregnant rats.
    SHELESNYAK MC
    Proc Soc Exp Biol Med; 1954 Nov; 87(2):377-8. PubMed ID: 13237249
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on the action of the hydrogenated alkaloids of the ergotoxine group on the circulation in man.
    BARCROFT H; KONZETT H; SWAN HJ
    J Physiol; 1951 Feb; 112(3-4):273-91. PubMed ID: 14825212
    [No Abstract]   [Full Text] [Related]  

  • 16. DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S68-71. PubMed ID: 12211142
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of prolactin secretion by ergolines.
    Clemens JA; Shaar CJ; Smalstig EB; Bach NJ; Kornfeld EC
    Endocrinology; 1974 Apr; 94(4):1171-6. PubMed ID: 4818776
    [No Abstract]   [Full Text] [Related]  

  • 18. Recreational use of ergoline alkaloids from Argyreia nervosa.
    Shawcross WE
    J Psychoactive Drugs; 1983; 15(4):251-9. PubMed ID: 6361223
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of serum prolactin in rats by 2 ergot alkaloids and 2 ergoline derivatives: a comparison.
    Brooks CL; Welsch CW
    Proc Soc Exp Biol Med; 1974 Jul; 146(3):863-7. PubMed ID: 4841203
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropharmacology of synthetic ergot derivatives in man.
    Lemberger L; Crabtree RE
    Adv Biochem Psychopharmacol; 1980; 23():117-24. PubMed ID: 6104905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.